In the 1980s, with the wide application of radioimmunoassay (6), it was found that serum AFP was significantly elevated in some patients with malignant tumors other than hepatocellular carcinoma and yolk cystic tumor, such as HAC. Here, AFP is linked to hepatocellular carcinoma.